Evidence map›Paper›PMID 38594676›Full record

ArticleRespiratory research2024

Targeting transitioning lung monocytes/macrophages as treatment strategies in lung disease related to environmental exposures.

Aaron D Schwab, Todd A Wyatt, Grace Moravec, Geoffrey M Thiele, Amy J Nelson, Angela Gleason, Oliver Schanze, Michael J Duryee, Debra J Romberger, Ted R Mikuls and 1 more

Open access · goldAbstract read
In one paragraph

Article in Respiratory research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Aaron D SchwabDivision of Allergy & Immunology, University of Nebraska Medical Center, Omaha, NE, USA.
Todd A WyattVeterans Affairs Nebraska-Western Iowa Health Care System, Research Service, Omaha, NE, USA.
Grace MoravecDivision of Allergy & Immunology, University of Nebraska Medical Center, Omaha, NE, USA.
Geoffrey M ThieleVeterans Affairs Nebraska-Western Iowa Health Care System, Research Service, Omaha, NE, USA.
Amy J NelsonDivision of Allergy & Immunology, University of Nebraska Medical Center, Omaha, NE, USA.
Angela GleasonDivision of Allergy & Immunology, University of Nebraska Medical Center, Omaha, NE, USA.
Oliver SchanzeDivision of Allergy & Immunology, University of Nebraska Medical Center, Omaha, NE, USA.
Michael J DuryeeVeterans Affairs Nebraska-Western Iowa Health Care System, Research Service, Omaha, NE, USA.
Debra J RombergerVeterans Affairs Nebraska-Western Iowa Health Care System, Research Service, Omaha, NE, USA.
Ted R MikulsVeterans Affairs Nebraska-Western Iowa Health Care System, Research Service, Omaha, NE, USA.
Jill A PooleDivision of Allergy & Immunology, University of Nebraska Medical Center, Omaha, NE, USA. japoole@unmc.edu.
University of Nebraska Medical Center · USNebraska Medical Center · US

Funding

Surveillance of Agricultural Injuries in the Central States RegionsU54OH010162 · OH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI RAUTIAINEN, RISTO HEIKKI · 2011 to 2025
$23.6M
Resolving Occupational Exposure-Induced Lung DiseaseR01OH012045 · OH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI POOLE, JILL A · 2021 to 2024
$2.3M
Targeting the ACOD1 immunometabolic pathway of lung myeloid cells to reduce environmental exposure-induced lung diseaseF30ES036063 · NIEHS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI SCHWAB, AARON · 2024 to 2025
$76k
Pathogenic Role of Malondialdehyde-Acetaldehyde Adducts in Rheumatoid ArthritisI01BX004660 · VA · OMAHA VA MEDICAL CENTER · PI MIKULS, TED RICHARD · 2020 to 2023
–
Reactive aldehydes and alcohol misuse in lung infectionsI01BX005886 · VA · OMAHA VA MEDICAL CENTER · PI WYATT, TODD A · 2023 to 2025
–
BLRD VA I01 BX004660BLRD VA I01 BX005886BLRD VA IK6 BX005962NIEHS NIH HHS F30 ES036063NIOSH CDC HHS R01 OH012045NIOSH CDC HHS R01OH012045NIOSH CDC HHS U54 OH010162NIOSH CDC HHS U54OH010162
6 · The paper itself

Abstract

backgroundEnvironmental/occupational exposures cause significant lung diseases. Agricultural organic dust extracts (ODE) and bacterial component lipopolysaccharide (LPS) induce recruited, transitioning murine lung monocytes/macrophages, yet their cellular role remains unclear.

methodsCCR2 RFP

resultsIntratracheal instillation of ODE, LPS, or PGN robustly induced the recruitment of inflammatory CCR2

conclusionHighly concentrated environmental/occupational exposures induced the recruitment of CCR2

Indexed as

Lung DiseasesMonocytesAnimalsCD8-Positive T-LymphocytesClodronic AcidCollagenEnvironmental ExposureLipopolysaccharidesLiposomesLungMacrophagesMiceMice, Inbred C57BLVimentinClodronic AcidCollagenLipopolysaccharidesLiposomesVimentinEndotoxinImmunologyInflammationLung diseaseMonocytesOrganic dust

Identifiers

PMID38594676
PMCPMC11003126
OpenAlexW4394609154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.